Gemcitabine combination with cisplatin in advanced non-small cell lung cancer
Lung Cancer. 1999;25:S31-S32 
P0021 Gemcitabine–docetaxel versus cisplatin–gemcitabine as first-line therapy in patients with metastatic non-small-cell lung cancer
European Journal of Cancer. 2014;50:e15
Gemcitabine and cisplatin as a first line therapy in non-small cell lung cancer
Lung Cancer. 1998;21:S33
2 The Hungarian experience with gemcitabine-cisplatin as first-line treatment of advanced non-small cell lung cancer: Focus on safety profile
Lung Cancer. 2003;41:S275
P-480 A comparative study of combination chemotherapy with docetaxell cisplatin versus gemcitabine/cisplatin for locally advanced non-small cell lung cancer
Lung Cancer. 2005;49:S242-S243
Phase I study of gemcitabine (GEM) and cisplatin (CP) for advanced non-small cell lung cancer (NSCLC)
Lung Cancer. 1994;11:116
Combination chemotherapy with gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: Preliminary results of an ongoing phase I/II study
Lung Cancer. 1996;15(1):152-153
P-6 A three drug combination chemotherapy with cisplatin, vinorelbine and gemcitabine for advanced (stage IIIB and IV) non-small cell lung cancer-A phase II study
Lung Cancer. 2003;41:S92
P-094 Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer
Lung Cancer. 2005;49:S246-S247
An International, Multicenter, Randomized Phase III Study of First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Versus First-Line Cisplatin/Gemcitabine Followed by Second-Line Erlotinib in Advanced Non–Small-Cell Lung Cancer: Treatment Rationale and Protocol Dynamics of the TORCH Trial
Clinical Lung Cancer. 2008;9(4):235-238